Ожирение и метаболизм

Расширенный поиск

Влияние динамики массы тела на факторы риска сердечно-сосудистых заболеваний у пациентов с сахарным диабетом 2 типа в течение первого года терапии инсулином

Полный текст:

Список литературы

1. American Diabetes Association. Standards of medical care of diabetes. Diabetes Care. 2009;32(1):13–S61.

2. Anderson JV, Kendall CV, Jenkins DJ. Importance of weight management in type 2 diabetes: review with meta-analyses of clinical studies. J Am CollNutr. 2003;22:331–339.

3. Bagg W, Plank LD, Gamble G, Drury PL, Sharpe N, Braatvedt GD. The effects of intensive glycaemic control on body composition in patients with type 2 diabetes. Diabetes, Obes and Metab. 2001;3:410–416.

4. Fagot-Campagna A, Rolka DB, Beckles JB, Greg EW, Narayan KM. Prevalence of lipid abnormalities, awareness, and treatment in US adults with diabetes. Diabetes. 2000;49 (Suppl. 1):78–86.

5. Hartman I. Insulin Analogues: Impact on treatment success, satisfaction, quality of life and adherence. Clinical Medicine and Research. 2008;6:54–67.

6. Henry RR, Gumbiner B, Ditzler T, Wallace P, Lyon R, Glauber HS. Intensive conventional insulin therapy for type 2 diabetes: metabolic effects during a 6-month outpatient trial. Diabetes Care. 1993;16:21–31.

7. Knowler WC, Pettitt DJ, Savage RJ. Diabetes incidence in Pima Indians: contributions of obesity and parental diabetes. Am J Epidemiol. 1981;113:144–156.

8. Larger E, Rufat P, Dubois-Laforgue D, Ledoux S. Insulin and weight gain: myth or reality? Diabetes Metab. 2001;27:23–27.

9. Larger E. Weight gain and insulin treatment. Diabetes Metab. 2005. Sep;31:4851–4856.

10. Makkimattila S, Nikkila K, Yki-Jarvinen H. Causes of weight gain during insulin therapy with and without metformin in patients with type 11 diabetes mellitus. Diabetologia. 1999;42:406–412.

11. Malmberg K. Prospective randomized study of intensive insulin treatment on long-term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ. 1997;314:1512–1515.

12. Nathan D M, Buse J B, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B. Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy. Diabetes Care. 2006;29:1963–1972.

13. Raz I, Wilson PW, Strojek K. et al. Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial. Diabetes Care. 2009;32:281–386.

14. Rigalleau V, Delafaye C, Baillet L. Composition of insulin-induced body weight gain in diabetic patients: a bio-impendance study. Diabetes Metab. 1999;25:321–328.

15. Robert R. Henry. Preventing cardiovascular complications of type 2 diabetes: focus on lipid management. Clinical Diabetes. 2001;19 (3):113–201.

16. Sinha A, Fomica C, Tsalamandris C. et al. Effects of insulin on body composition in patients with insulin-dependent and non-insulin-dependent diabetes mellitus. Diabetic Med. 1996;13:40–46.

17. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood- glucose control with sulfonylureas or insulin compared to conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–853.

18. Wolffenbuttel BH, Leurs BP, Sels JP et al. Improved blood glucose control by insulin in type 2 diabetic patients has no effect on lipoprotein (a) levels. Diabetic Med. 1993;10:427–430.


Для цитирования:

Dzhavakhishvili T.S., Romantsova T.I., Roik O.V. Влияние динамики массы тела на факторы риска сердечно-сосудистых заболеваний у пациентов с сахарным диабетом 2 типа в течение первого года терапии инсулином. Ожирение и метаболизм. 2013;10(1):22-25.

For citation:

., ., . Influence of the dynamics of body weight on the risk factors of cardiovascular disease in patients with type 2 diabetes during the first year of insulin treatment. Obesity and metabolism. 2013;10(1):22-25. (In Russ.)

Просмотров: 270

ISSN 2071-8713 (Print)
ISSN 2306-5524 (Online)